Evaluation of cytomegalovirus-specific cytotoxic T-lymphocytes in patients with the HLA-A*02 or HLA-A*24 phenotype undergoing hematopoietic stem cell transplantation.

Morita, Y; Hosokawa, M; Ebisawa, M; Sugita, T; Miura, O; Takaue, Y; Heike, Y

Morita, Y; Hosokawa, M; Ebisawa, M; Sugita, T; Miura, O; Takaue, Y; Heike, Y.

Affiliation

Morita Y; Division of Hematology and Stem Cell Transplantation, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.

Bone Marrow Transplant ; 36(9): 803-11, 2005 Nov.

Article in En | MEDLINE | ID: mdl-16113668

Subject(s)

Cytomegalovirus/immunology; HLA-A Antigens/immunology; Hematopoietic Stem Cell Transplantation; Neoplasms/immunology; T-Lymphocytes, Cytotoxic/immunology; Adult; Aged; Antigens, Viral/immunology; Cells, Cultured; Epitopes, T-Lymphocyte/immunology; Female; HLA-A2 Antigen; HLA-A24 Antigen; Hematopoietic Stem Cell Transplantation/methods; Humans; Interferon-gamma/immunology; Male; Middle Aged; Neoplasms/therapy; Neoplasms/virology; Phenotype; Transplantation, Homologous; Virus Activation/immunology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / HLA-A Antigens / Hematopoietic Stem Cell Transplantation / Cytomegalovirus / Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2005 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links